Hudson River Biotechnology raised €5.0M in a Series A round in Aug 2021. The company is based in Wageningen, Netherlands. Investors in the round: Bridford Group. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €5.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
